NDC11 63824043801
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 63824-0438-01 | 63824-0438 |
| 63824-0438-1 | 63824-0438 |
| 63824-438-01 | 63824-438 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clearasil Stubborn Acne Control 5in1 Spot Treatment | BENZOYL PEROXIDE | Reckitt Benckiser LLC | bdb87e60-67a6-4c0e-b0ab-3e238a08269c | 2026-05-13 | Warnings | 63824-438-01 63824-438 63824043801 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.